Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Cancer

Explore clinical trials studying Triple Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

298 public trials 111 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Cancer trial results

Active, not recruiting

Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

NCT03281954

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
  • St. Bernard's Medical Center Jonesboro, Arkansas, United States
  • St. Bernard's Medical Center Paragould, Arkansas, United States
View all 217 locations
View Trial Details
Completed

Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer

NCT06604858

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Complejo Hospitalario Universitario A Coruña (CHUAC) A Coruña, Spain
  • Hospital Universitari Dexeus Barcelona, Spain
  • Hospital Universitari Vall D'Hebron Barcelona, Spain
  • Institut Català d' Oncologia Girona (ICO) Girona, Spain
View Trial Details
Completed

A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

NCT03289962

Conditions
Bladder Cancer, Breast Diseases, Breast Neoplasms, +48 more
Locations
  • HonorHealth Research Institute ? Bisgrove Scottsdale, Arizona, United States
  • The Los Angeles Clinic Los Angeles, California, United States
  • UCSF Comprehensive Cancer Ctr San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 33 locations
View Trial Details
Completed

Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.

NCT05181462

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Hospital Universitario Virgen de las Nieves Granada, Andalusia, Spain
  • Hospital Universitario Clinico San Cecilio Granada, Andalusia, Spain
  • Complejo Hospitalario de Jaén Jaén, Andalusia, Spain
  • Hospital Universitario Virgen De La Victoria Málaga, Andalusia, Spain
View all 23 locations
View Trial Details
Completed

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

NCT03797326

Conditions
Adnexal Diseases, Advanced Solid Tumors, Astrocytoma, +49 more
Locations
  • City of Hope ( Site 0002) Duarte, California, United States
  • Cedars Sinai Medical Center ( Site 0003) Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center ( Site 0005) Sacramento, California, United States
  • University of Colorado, Anschutz Cancer Pavilion ( Site 0007) Aurora, Colorado, United States
View all 88 locations
View Trial Details

Related conditions